CAS 62019-71-0

Thieno[2,3-c]pyridine, 4,5,6,7-tetrahydro-

Description:

Thieno[2,3-c]pyridine, 4,5,6,7-tetrahydro- is a heterocyclic organic compound characterized by a fused ring system that includes both sulfur and nitrogen atoms. This compound features a thieno ring, which is a five-membered ring containing sulfur, fused to a pyridine ring, a six-membered aromatic ring containing nitrogen. The "tetrahydro" designation indicates that the compound has four additional hydrogen atoms, resulting in a saturated structure that contributes to its stability and reactivity. Typically, such compounds exhibit interesting biological activities and can serve as potential pharmacophores in medicinal chemistry. The presence of the sulfur and nitrogen atoms in the ring system can influence the compound's electronic properties, making it a candidate for various applications, including in the development of pharmaceuticals and agrochemicals. Additionally, thieno[2,3-c]pyridine derivatives are often explored for their potential in organic electronics and materials science due to their unique structural features.

Formula: C₇H₉NS

4H,5H,6H,7H-thieno[2,3-c]pyridine

CAS: 62019-71-0

Formula: C₇H₉NS

Molecular weight: 139.2181

Ref: IN-DA00EFUV

4H,5H,6H,7H-Thieno[2,3-c]pyridine

CAS: 62019-71-0

Purity: 95+%

Molecular weight: 139.2200012

Ref: 10-F624685

4,5,6,7-Tetrahydrothieno[2,3-c]pyridine

CAS: 62019-71-0

This heterocycle is a potent inhibitor of the enzyme called nitroreductase, which is involved in the synthesis of nitroaromatic compounds that are carcinogenic. It has been shown to induce apoptotic cell death by binding to the skeleton and inhibiting protein synthesis. The drug also interacts with mononuclear cells, inducing apoptosis in those cells at low doses and cytotoxicity at higher doses. This agent has been shown to have inhibitory activity against cancer cells and can be used for treatment of cancers such as colon cancer.

Formula: C₇H₉NS

Purity: Min. 95%

Molecular weight: 139.22 g/mol

Ref: 3D-MCA01971